chronic intestinal pseudo-obstruction (CIPO) research hub

A TWO-PART ABSOLUTE BIOAVAILABILITY STUDY DESIGNED TO EVALUATE THE PHARMACOKINETIC PROFILE OF VELUSETRAG FOLLOWING SINGLE-DOSE ADMINISTRATION OF INTRAVENOUS AND ORAL CAPSULE FORMULATIONS IN HEALTHY MALE AND FEMALE SUBJECTS

This study is looking at how a new medicine, velusetrag, acts in the body when given by mouth as a capsule or through a drip. It aims to understand how much of the medicine gets into the bloodstream and how long it stays there in healthy adults.